Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cytoclonal describes recent progress in telomerase production, inhibitors

Dec. 23, 1999

Targretin overcomes tamoxifen resistance in preclinical testing

Dec. 23, 1999

New FTase inhibitors from Schering-Plough with good cellular activity

Dec. 22, 1999

Cytotoxic polyheterocyclic compounds designed at Taiwan research institute

Dec. 22, 1999

Dynal to provide component for Xcyte Therapies' activated T-cell product

Dec. 22, 1999

Sumitomo applies for approval of amrubicin

Dec. 22, 1999

AstraZeneca commences phase II monotherapy trials of ZD-0473

Dec. 21, 1999

Discovery of potent FTase inhibitors with excellent cellular and in vivo activity reported by Abbott

Dec. 21, 1999

Oxford Asymmetry achieves first milestone in collaboration with Ontogeny

Dec. 21, 1999

Phase I clinical trial initiated with OSI's second anticancer agent

Dec. 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...